Assertio Holdings (ASRT) Depreciation & Amortization (CF) (2019 - 2026)

Assertio Holdings' (ASRT) quarterly Depreciation & Amortization (CF) came in at $5.8 million in Q1 2026, down 36.99% year-on-year from $9.3 million in Q1 2025, and little changed quarter-over-quarter from $5.8 million in Q4 2025.

Assertio Holdings (ASRT) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Assertio Holdings has disclosed Depreciation & Amortization (CF) across 8 years of filings, most recently posting $5.8 million for Q1 2026.

  • Depreciation & Amortization (CF) for Q1 2026 came in at $5.8 million, down 36.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.6 million (down 9.61% YoY), and the FY2025 annual result was $30.0 million, up 16.17% from the prior year.
  • Depreciation & Amortization (CF) came in at $5.8 million for Q1 2026 at Assertio Holdings, roughly flat from $5.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $10.4 million in Q3 2023 to a low of $4.9 million in Q4 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $6.7 million (2024), against an average of $7.3 million.
  • Across the five-year window, Depreciation & Amortization (CF) slumped 41.31% in 2023 and surged 62.73% in 2025, its largest moves.
  • Assertio Holdings' Depreciation & Amortization (CF) stood at $8.4 million in 2022, then sank by 41.31% to $4.9 million in 2023, then jumped by 36.74% to $6.7 million in 2024, then declined by 12.99% to $5.8 million in 2025, then advanced by 0.02% to $5.8 million in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $5.8 million (Q1 2026), $5.8 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 239.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 22.60 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 19.43 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 21.95 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 22.68 Mn
10 Assertio Holdings 150.94 Mn 79.37 Mn 7.22 Mn 5.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.84 Mn
Mar 31, 2026 5.84 Mn
Dec 31, 2025 5.84 Mn
Dec 31, 2025 5.84 Mn
Sep 30, 2025 5.63 Mn
Sep 30, 2025 5.63 Mn
Jun 30, 2025 9.27 Mn
Jun 30, 2025 9.27 Mn
Mar 31, 2025 9.27 Mn
Mar 31, 2025 9.27 Mn
Dec 31, 2024 6.71 Mn
Dec 31, 2024 6.71 Mn
Sep 30, 2024 6.71 Mn
Sep 30, 2024 6.71 Mn
Jun 30, 2024 6.71 Mn
Jun 30, 2024 6.71 Mn
Mar 31, 2024 5.70 Mn
Mar 31, 2024 5.70 Mn
Dec 31, 2023 4.91 Mn
Dec 31, 2023 4.91 Mn